Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 404 followers

Latest posts

Last updated about 16 hours ago

Accelerating clinical trials with precision logistics

about 16 hours ago

Learn how Marken’s Laboratory Advantage improves speed, visibility and compliance to keep...

FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs

about 20 hours ago

The FDA rejected two new products from AbbVie and Grace Therapeutics, citing...

Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval

about 20 hours ago

After a series of setbacks for Sanofi’s tolebrutinib, the French company has...

Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’

about 21 hours ago

Daiichi Sankyo has postponed its annual report by two weeks, citing additional...

Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst

about 21 hours ago

An established sales force and payer authorization criteria will fuel a fast...

Genentech wants ‘All Eyes on DME’ as it taps Damon Wayans for humor-laced campaign

about 22 hours ago

Roche’s Genentech unit is launching a new multimedia campaign aimed at sharing...

Can Trump’s deal with the UK become a model for similar drug price agreements?

about 22 hours ago

Trump’s deal with the UK links tariffs to drug pricing. On this...

Pfizer's cost-cutting push reaches Ireland again as it plans manufacturing layoffs

about 23 hours ago

During Pfizer's right-sizing push after the COVID-19 pandemic, the company's multibillion-dollar cost-cutting...

Pfizer drafts Fernando Mendoza as new face of its ‘game of inches’ cancer campaign

about 23 hours ago

Pfizer is kicking off the next stage of its cancer awareness program...

Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO

about 23 hours ago

Merck & Co. unveiled the much-anticipated first look at its PD-1xVEGF bispecific...

Avalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs

about 24 hours ago

Avalyn Pharma is hoping to rake in around $181.8 million from an...

Patients less confident than ever about health choices: survey

1 day ago

Patients’ confidence in their ability to find answers about health questions and...